Clinical Trial Update: Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase II study of tazemetostat in combination with mosunetuzumab for untreated follicular lymphoma; the trial is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Mosunetuzumab (mosunetuzumab)
• Tazemetostat (tazemetostat)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Follicular Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING